The Effects of Neuregulin on Cardiac Myosin Light Chain Kinase Gene-Ablated Hearts

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Chang, Audrey N ^a   Huang, Jian ^a   Battiprolu, Pavan K ^a   Hill, Joseph A ^a,b   Kamm, Kristine E ^a   Stull, James T ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CARDIAC MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; MYOSIN REGULATORY LIGHT CHAIN; NEU DIFFERENTIATION FACTOR; PHOSPHOLAMBAN; PROTEIN KINASE B; RNA; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART PERFORMANCE; HEART VENTRICLE HYPERTROPHY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA ANALYSIS; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; HEART; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOSIN-LIGHT-CHAIN KINASE; NEUREGULINS; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA; MUS; RODENTIA;

EID: 84878820150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066720     Document Type: Article

References (31)

1. Wadugu B, Kuhn B, (2012) The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation. Am J Physiol Heart Circ Physiol 302: H2139-2147.
2. Bersell K, Arab S, Haring B, Kuhn B, (2009) Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138: 257-270.
3. Bian Y, Sun M, Silver M, Ho KK, Marchionni MA, et al. (2009) Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol 297: H1974-1983.
4. Lemmens K, Doggen K, De Keulenaer GW, (2007) Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 116: 954-960.
5. Pentassuglia L, Sawyer DB, (2009) The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 315: 627-637.
6. Citri A, Yarden Y, (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505-516.
7. Gu X, Liu X, Xu D, Li X, Yan M, et al. (2010) Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulin. Cardiovasc Res 88: 334-343.
8. Seguchi O, Takashima S, Yamazaki S, Asakura M, Asano Y, et al. (2007) A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest 117: 2812-2824.
9. Chan JY, Takeda M, Briggs LE, Graham ML, Lu JT, et al. (2008) Identification of cardiac-specific myosin light chain kinase. Circ Res 102: 571-580.
10. Ding P, Huang J, Battiprolu PK, Hill JA, Kamm KE, et al. (2010) Cardiac myosin light chain kinase is necessary for myosin regulatory light chain phosphorylation and cardiac performance in vivo. J Biol Chem 285: 40819-40829.
11. Kamm KE, Stull JT, (2011) Signaling to myosin regulatory light chain in sarcomeres. J Biol Chem 286: 9941-9947.
12. Olsson MC, Patel JR, Fitzsimons DP, Walker JW, Moss RL, (2004) Basal myosin light chain phosphorylation is a determinant of Ca2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am J Physiol Heart Circ Physiol 287: H2712-2718.
13. Stelzer JE, Patel JR, Moss RL, (2006) Acceleration of stretch activation in murine myocardium due to phosphorylation of myosin regulatory light chain. J Gen Physiol 128: 261-272.
14. Sheikh F, Ouyang K, Campbell SG, Lyon RC, Chuang J, et al. (2012) Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. J Clin Invest 122: 1209-1221.
15. Sanbe A, Fewell JG, Gulick J, Osinska H, Lorenz J, et al. (1999) Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem 274: 21085-21094.
16. Scruggs SB, Hinken AC, Thawornkaiwong A, Robbins J, Walker LA, et al. (2009) Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem 284: 5097-5106.
17. Huang J, Shelton JM, Richardson JA, Kamm KE, Stull JT, (2008) Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy. J Biol Chem 283: 19748-19756.
18. Warren SA, Briggs LE, Zeng H, Chuang J, Chang EI, et al. (2012) Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 126: 2575-2588.
19. Kamm KE, Stull JT, (2001) Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276: 4527-4530.
20. Sakai K, Miyazaki J, (1997) A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun 237: 318-324.
21. Collins KA, Korcarz CE, Shroff SG, Bednarz JE, Fentzke RC, et al. (2001) Accuracy of echocardiographic estimates of left ventricular mass in mice. Am J Physiol Heart Circ Physiol 280: H1954-1962.
22. Kamm KE, Hsu LC, Kubota Y, Stull JT, (1989) Phosphorylation of smooth muscle myosin heavy and light chains. Effects of phorbol dibutyrate and agonists. J Biol Chem 264: 21223-21229.
23. Kuramochi Y, Guo X, Sawyer DB, (2006) Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol 41: 228-235.
24. Liu X, Gu X, Li Z, Li X, Li H, et al. (2006) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48: 1438-1447.
25. Sandri M, (2008) Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23: 160-170.
26. Chaanine AH, Hajjar RJ, (2011) AKT signalling in the failing heart. Eur J Heart Fail 13: 825-829.
27. Mattiazzi A, Mundina-Weilenmann C, Guoxiang C, Vittone L, Kranias E, (2005) Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 68: 366-375.
28. Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, et al. (2003) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92: 912-919.
29. Kranias EG, Hajjar RJ, (2012) Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 110: 1646-1660.
30. Anderson ME, Brown JH, Bers DM, (2011) CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51: 468-473.
31. Mishra S, Gray CB, Miyamoto S, Bers DM, Brown JH, (2011) Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Circ Res 109: 1354-1362.